Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Improved Assays in Pain Research Using Native Neurons

Published: Saturday, May 10, 2014
Last Updated: Saturday, May 10, 2014
Bookmark and Share
Cellectricon and Neusentis to present a webinar on May 16, from 11am EDT.

Cellectricon will co-host a webinar with Neusentis, describing the use of native cells to develop an assay with improved physiological relevance over traditional approaches in pain drug discovery research.

Entitled ‘Development of Cell-Based Assays for Pain Drug Discovery Using Native Sensory Neurons’, the webinar will take place on May 16 at 11am EDT; researchers can register at www.cellecticon.com/events.

Cellectricon is creating model systems with native neurons for registering changes in neural activity - both at the cellular and network level - using its Cellaxess® Elektra discovery platform, and Neusentis is a Pfizer Research Unit focusing on pain and sensory disorders.

Webinar participants will gain further understanding of the underlying mechanisms causing chronic pain, and learn more about phenotypic screening approaches in pain research and the use of compound profiling to advance research in the CNS and pain therapeutic fields.

Presentations from Dr Darren Cawkill, Associate Research Fellow at Neusentis, and Dr Paul Karila, VP Discovery Services, Cellectricon, will cover the results from their assay development work. Dr Cawkill will go on to present data from an additional phenotypic screening case study, which describes the progress towards high-throughput compatible assays using both primary rat neuronal cultures and human stem cell-derived sensory neurons. There will also be a discussion on how such phenotypic screening assays could be integrated into drug discovery programs.

Aimed at R&D scientists working in drug discovery, neuroscience, translational science, high content biology, electrophysiology and ion channel research, ‘Development of Cell-Based Assays for Pain Drug Discovery Using Native Sensory Neurons’, will take place at 11am EDT on May 16.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cellectricon Receives Milestone Order for Cellaxess®HT High Throughput RNAi Screening System
Cellectricon receives the largest single order to deliver three Cellaxess®HT systems to a leading US biotech firm.
Friday, November 14, 2008
Scientific News
Crucial for Stem Cell Survival Protein Identified Using Editing Tool CRISPR
A team of University of Wisconsin-Madison engineers has identified a protein that is integral to the survival and self-renewal processes of human pluripotent stem cells (hPSC).
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!